This is a StreetInsider.com Premium Only Page

(RPTX) –

Apr 19, 2024 08:28 AM Bloom Burton & Co. Upgrades Repare Therapeutics (RPTX) to Buy (1)

Apr 1, 2024 09:32 PM Form 4 Repare Therapeutics Inc. For: Mar 28 Filed by: Segal Lloyd Mitchell

Apr 1, 2024 09:30 PM Form 4 Repare Therapeutics Inc. For: Mar 28 Filed by: Forte Steve

Apr 1, 2024 09:29 PM Form 4 Repare Therapeutics Inc. For: Mar 28 Filed by: Zinda Michael

Apr 1, 2024 09:27 PM Form 4 Repare Therapeutics Inc. For: Mar 28 Filed by: Koehler Maria

Mar 27, 2024 06:59 PM Form 4 Repare Therapeutics Inc. For: Mar 25 Filed by: Forte Steve

Mar 27, 2024 06:58 PM Form 4 Repare Therapeutics Inc. For: Mar 25 Filed by: Zinda Michael

Mar 27, 2024 06:56 PM Form 4 Repare Therapeutics Inc. For: Mar 25 Filed by: Koehler Maria

Mar 27, 2024 06:55 PM Form 4 Repare Therapeutics Inc. For: Mar 25 Filed by: Segal Lloyd Mitchell

Mar 27, 2024 12:38 PM Form 144 Repare Therapeutics Inc. Filed by: Forte Steve

Mar 26, 2024 02:50 PM Form 144 Repare Therapeutics Inc. Filed by: Segal Lloyd Mitchell

Mar 25, 2024 07:25 PM Form 144 Repare Therapeutics Inc. Filed by: Segal Lloyd Mitchell

Mar 25, 2024 04:24 PM Form 144 Repare Therapeutics Inc. Filed by: Zinda Michael

Mar 25, 2024 04:23 PM Form 144 Repare Therapeutics Inc. Filed by: Koehler Maria

Mar 5, 2024 04:16 PM Form 4 Repare Therapeutics Inc. For: Mar 01 Filed by: Forte Steve

Mar 4, 2024 09:07 PM Form 4 Repare Therapeutics Inc. For: Mar 01 Filed by: Zinda Michael

Mar 4, 2024 09:05 PM Form 4 Repare Therapeutics Inc. For: Mar 01 Filed by: Segal Lloyd Mitchell

Mar 4, 2024 09:03 PM Form 4 Repare Therapeutics Inc. For: Mar 01 Filed by: Koehler Maria

Feb 29, 2024 07:05 AM Repare Therapeutics to Participate in Two Upcoming Investor Conferences

Feb 28, 2024 04:13 PM Form S-8 Repare Therapeutics Inc.

Feb 28, 2024 07:53 AM Repare Therapeutics Inc. (RPTX) Misses Q4 EPS by 31c

Feb 28, 2024 07:17 AM Form 10-K Repare Therapeutics Inc. For: Dec 31

Feb 28, 2024 07:10 AM Form 8-K Repare Therapeutics Inc. For: Feb 28

Feb 28, 2024 07:05 AM Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 20, 2024 09:00 PM REPARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Repare Therapeutics Inc. on Behalf of Repare Stockholders and Encourages Investors to Contact the Firm

Feb 15, 2024 07:05 AM Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-1664

Feb 14, 2024 09:03 PM Form SC 13G Repare Therapeutics Inc. Filed by: Blue Owl Capital Holdings LP

Feb 14, 2024 04:27 PM Form SC 13G/A Repare Therapeutics Inc. Filed by: Redmile Group, LLC

Feb 14, 2024 08:54 AM Form SC 13G/A Repare Therapeutics Inc. Filed by: Deep Track Capital, LP

Feb 14, 2024 06:36 AM Repare Therapeutics (RPTX) PT Lowered to $10 at H.C. Wainwright

Feb 13, 2024 07:33 AM Bloom Burton & Co. Downgrades Repare Therapeutics (RPTX) to Accumulate (2)

Feb 12, 2024 04:48 PM Form 8-K Repare Therapeutics Inc. For: Feb 07

Feb 12, 2024 04:07 PM Repare Therapeutics Inc. (RPTX) to Regain Global Rights to Camonsertib

Feb 12, 2024 04:05 PM Repare Therapeutics to Regain Global Rights to Camonsertib

Jan 29, 2024 04:01 PM Form SC 13G/A Repare Therapeutics Inc. Filed by: ARK Investment Management LLC

Jan 25, 2024 02:29 PM Form 8-K Repare Therapeutics Inc. For: Jan 25

Jan 25, 2024 07:02 AM Repare Therapeutics Inc. (RPTX) Achieves $40M Roche Clinical Milestone Payment

Jan 25, 2024 07:00 AM Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment

Jan 12, 2024 04:06 PM Form 8-K Repare Therapeutics Inc. For: Jan 08

Jan 8, 2024 07:00 AM Repare Therapeutics Provides Corporate Update and Highlights Anticipated Key 2024 Milestones

Jan 4, 2024 04:10 PM Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer

Jan 4, 2024 04:05 PM Repare Therapeutics and Debiopharm Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer

Dec 29, 2023 04:06 PM Repare Therapeutics (RPTX) Insiders Establish Automatic Securities Disposition Plans

Dec 29, 2023 04:05 PM Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans

Dec 12, 2023 04:19 PM Form 4 Repare Therapeutics Inc. For: Dec 11 Filed by: Koehler Maria

Nov 17, 2023 04:55 PM Form 4 Repare Therapeutics Inc. For: Nov 15 Filed by: BVF II GP LLC

Nov 17, 2023 04:53 PM Form SC 13D/A Repare Therapeutics Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Nov 15, 2023 07:34 AM Form 8-K Repare Therapeutics Inc. For: Nov 15

Nov 15, 2023 07:00 AM Repare Therapeutics Unveils Two Programs Expected to Enter Clinical Trials in 2024: RP-1664, an Oral PLK4 Inhibitor, and RP-3467, an Oral Polθ Inhibitor

Nov 9, 2023 07:53 AM Repare Therapeutics Inc. (RPTX) Tops Q3 EPS by 41c